Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2020 Filed Jul 16, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $49.54 | $247,683.00 |
DisclosureSEC source: 0001209191-20-042652 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,314 | $5.18 | $11,974.95 |
DisclosureSEC source: 0001209191-20-042652 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 10,186 | $1.58 | $16,042.95 |
DisclosureSEC source: 0001209191-20-042652 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-042653 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,055 Underlying: Common Stock · 7,900 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 7,900 | $48.85 | $385,876.29 |
DisclosureSEC source: 0001209191-20-042653 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.7897 to $48.8922, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 7,900 | $1.53 | $12,087.00 |
DisclosureSEC source: 0001209191-20-042653 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 20:50 UTC |
Horn HowardCFO
|
SaleCommon Stock | 30,000 | $50.06 | $1,501,731.00 |
DisclosureSEC source: 0001209191-20-042489 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 10, 2020 Filed Jul 15, 2020 00:22 UTC |
Sigal Charles ElliottDirector
|
GrantStock Option (Right to Buy) · Derivative | 57,777 | $0.00 Strike: $48.71 | $0.00 |
DisclosureSEC source: 0001209191-20-042454 · doc4.xml · derivative · entry 1 Sigal Charles Elliott · CIK 0001661908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,777 Underlying: Common Stock · 57,777 shares Expires 2030-07-10 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on July 10, 2021, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| July 10, 2020 Filed Oct 13, 2020 23:16 UTC Amendment |
Sigal Charles ElliottDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,394 | $0.00 Strike: $48.71 | $0.00 |
DisclosureSEC source: 0001209191-20-054743 · doc4a.xml · derivative · entry 1 Sigal Charles Elliott · CIK 0001661908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,394 Underlying: Common Stock · 28,394 shares Expires 2030-07-09 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on July 10, 2021, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| July 02, 2020 Filed Jul 2, 2020 22:42 UTC |
Horn HowardCFO
|
SaleCommon Stock | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001209191-20-040660 · doc4.xml · nonDerivative · entry 4 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:43 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 49,075 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-040664 · doc4.xml · derivative · entry 5 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,035 Underlying: Common Stock · 49,075 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:43 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,925 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-040664 · doc4.xml · derivative · entry 4 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,296 Underlying: Common Stock · 25,925 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:43 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 75,000 | $37.95 | $2,846,310.00 |
DisclosureSEC source: 0001209191-20-040664 · doc4.xml · nonDerivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.944 to $37.956, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:43 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 49,075 | $1.58 | $77,293.13 |
DisclosureSEC source: 0001209191-20-040664 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:43 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 25,925 | $1.49 | $38,498.63 |
DisclosureSEC source: 0001209191-20-040664 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,722 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-040662 · doc4.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,338 Underlying: Common Stock · 9,722 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,778 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-040662 · doc4.xml · derivative · entry 5 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,333 Underlying: Common Stock · 2,778 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $37.77 | $188,840.50 |
DisclosureSEC source: 0001209191-20-040662 · doc4.xml · nonDerivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $37.79 | $283,411.50 |
DisclosureSEC source: 0001209191-20-040662 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 9,722 | $5.18 | $50,311.35 |
DisclosureSEC source: 0001209191-20-040662 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 2,778 | $1.58 | $4,375.35 |
DisclosureSEC source: 0001209191-20-040662 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Horn HowardCFO
|
SaleCommon Stock | 400 | $39.33 | $15,732.00 |
DisclosureSEC source: 0001209191-20-040660 · doc4.xml · nonDerivative · entry 3 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Horn HowardCFO
|
SaleCommon Stock | 500 | $38.78 | $19,392.00 |
DisclosureSEC source: 0001209191-20-040660 · doc4.xml · nonDerivative · entry 2 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,177 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price and includes 200 shares sold at $38.19 and 300 shares sold at $39.18. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:42 UTC |
Horn HowardCFO
|
SaleCommon Stock | 9,100 | $37.72 | $343,274.75 |
DisclosureSEC source: 0001209191-20-040660 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,677 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.16 to $38.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 01, 2020 Filed Jul 16, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,314 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-042652 · doc4.xml · derivative · entry 6 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,024 Underlying: Common Stock · 2,314 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2020 Filed Jul 16, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,186 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-042652 · doc4.xml · derivative · entry 5 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,147 Underlying: Common Stock · 10,186 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 21:00 UTC |
Horn HowardCFO
|
SaleCommon Stock | 30,000 | $50.00 | $1,500,000.00 |
DisclosureSEC source: 0001209191-20-039103 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 00:23 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,360 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-038791 · doc4.xml · derivative · entry 6 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,955 Underlying: Common Stock · 9,360 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 00:23 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 9,360 | $48.00 | $449,280.00 |
DisclosureSEC source: 0001209191-20-038791 · doc4.xml · nonDerivative · entry 4 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 00:23 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 9,360 | $1.53 | $14,320.80 |
DisclosureSEC source: 0001209191-20-038791 · doc4.xml · nonDerivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 00:23 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,560 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-038791 · doc4.xml · derivative · entry 5 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,315 Underlying: Common Stock · 5,560 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 00:23 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 5,560 | $38.99 | $216,777.73 |
DisclosureSEC source: 0001209191-20-038791 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.8480 to $39.1605, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 00:23 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 5,560 | $1.53 | $8,506.80 |
DisclosureSEC source: 0001209191-20-038791 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:00 UTC |
Horn HowardCFO
|
SaleCommon Stock | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001209191-20-038511 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,510 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-038510 · doc4.xml · derivative · entry 4 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,875 Underlying: Common Stock · 3,510 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,755 | $38.00 | $66,690.00 |
DisclosureSEC source: 0001209191-20-038510 · doc4.xml · nonDerivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,755 | $38.00 | $66,694.04 |
DisclosureSEC source: 0001209191-20-038510 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,755 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,510 | $1.53 | $5,370.30 |
DisclosureSEC source: 0001209191-20-038510 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-037646 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,110 Underlying: Common Stock · 12,500 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $37.26 | $279,472.50 |
DisclosureSEC source: 0001209191-20-037646 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $37.27 | $186,342.00 |
DisclosureSEC source: 0001209191-20-037646 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:00 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 12,500 | $5.18 | $64,687.50 |
DisclosureSEC source: 0001209191-20-037646 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-035975 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,385 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $36.28 | $138,030.18 |
DisclosureSEC source: 0001209191-20-035975 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.2691 to $36.2869, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-035975 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:53 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001209191-20-034452 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,610 Underlying: Common Stock · 12,500 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:53 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 7,500 | $35.06 | $262,932.00 |
DisclosureSEC source: 0001209191-20-034452 · doc4.xml · nonDerivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:53 UTC |
Pang PhillipChief Medical Officer
|
SaleCommon Stock | 5,000 | $35.09 | $175,455.00 |
DisclosureSEC source: 0001209191-20-034452 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:53 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 12,500 | $5.18 | $64,687.50 |
DisclosureSEC source: 0001209191-20-034452 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 01:15 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-033780 · doc4.xml · derivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,221 Underlying: Common Stock · 75,000 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.